Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 9/20 | 0.49 |
| ▸ | PARP1 | P09874 | 1/20 | 0.45 |
| ▸ | DPP4 | P27487 | 4/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.43 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.43 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.43 |
| ▸ | ANPEP | P15144 | 1/20 | 0.43 |
| ▸ | FAP | Q12884 | 1/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17397380 | 0.97 | PRCP (0.46) | PRCPPARP1DPP4DPP8HCRTR1 | |
| SCHEMBL17397409 | 0.87 | PARP1 (0.42) | PRCPPARP1DPP4DPP8HCRTR1 | |
| SCHEMBL3344066 | 0.76 | KCNH2 (0.53) | PRCPHCRTR1HCRTR2 | |
| SCHEMBL3344057 | 0.76 | KCNH2 (0.53) | PRCPHCRTR1HCRTR2 | |
| SCHEMBL1745251 | 0.74 | KCNH2 (0.57) | PRCPHCRTR1HCRTR2 | |
| SCHEMBL1745248 | 0.74 | KCNH2 (0.57) | PRCPHCRTR1HCRTR2 | |
| SCHEMBL19578392 | 0.73 | PRCP (0.60) | PRCPHCRTR1HCRTR2 | |
| SCHEMBL18815710 | 0.72 | PRCP (0.72) | PRCPHCRTR1HCRTR2 | |
| SCHEMBL18815709 | 0.72 | PRCP (0.72) | PRCPHCRTR1HCRTR2 | |
| SCHEMBL18815797 | 0.71 | PRCP (0.53) | PRCPHCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016003827-A2 | FUSED CYCLOALKYL-PYRIMIDINE COMPOUNDS AND USES THEREOF | MEDIVATION TECHNOLOGIES, INC. (US) | 2016-01-07 | — | — | WO | disclosed |